CEL Operating Cash Flow Per Share vs Days Sales Outstanding Analysis

CVM Stock  USD 0.65  0.04  5.80%   
CEL SCI financial indicator trend analysis is way more than just evaluating CEL SCI Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CEL SCI Corp is a good investment. Please check the relationship between CEL SCI Operating Cash Flow Per Share and its Days Sales Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Operating Cash Flow Per Share vs Days Sales Outstanding

Operating Cash Flow Per Share vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CEL SCI Corp Operating Cash Flow Per Share account and Days Sales Outstanding. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between CEL SCI's Operating Cash Flow Per Share and Days Sales Outstanding is -0.14. Overlapping area represents the amount of variation of Operating Cash Flow Per Share that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of CEL SCI Corp, assuming nothing else is changed. The correlation between historical values of CEL SCI's Operating Cash Flow Per Share and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Cash Flow Per Share of CEL SCI Corp are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Operating Cash Flow Per Share i.e., CEL SCI's Operating Cash Flow Per Share and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.14
Relationship DirectionNegative 
Relationship StrengthInsignificant

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Days Sales Outstanding

Most indicators from CEL SCI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CEL SCI Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
As of the 16th of December 2024, Enterprise Value is likely to grow to about 82.9 M, while Selling General Administrative is likely to drop about 5.2 M.
 2021 2022 2023 2024 (projected)
Total Operating Expenses36.1M31.5M36.2M38.0M
Cost Of Revenue3.9M4.0M3.6M3.1M

CEL SCI fundamental ratios Correlations

0.030.160.890.85-0.48-0.760.910.870.910.75-0.180.740.520.750.91-0.430.60.640.59-0.32-0.07-0.45-0.250.45-0.27
0.030.42-0.240.280.48-0.23-0.220.31-0.20.22-0.40.310.480.38-0.21-0.070.410.24-0.29-0.20.3-0.170.0-0.15-0.04
0.160.42-0.20.320.33-0.4-0.020.32-0.030.09-0.110.310.770.28-0.03-0.190.590.570.27-0.580.92-0.17-0.32-0.29-0.32
0.89-0.24-0.20.62-0.68-0.50.90.640.910.57-0.050.490.080.560.92-0.290.190.280.53-0.15-0.39-0.32-0.170.63-0.17
0.850.280.320.62-0.01-0.830.610.980.60.92-0.540.860.660.920.58-0.670.690.760.62-0.570.05-0.65-0.440.19-0.48
-0.480.480.33-0.68-0.01-0.07-0.74-0.03-0.750.06-0.30.110.190.06-0.76-0.070.070.18-0.18-0.370.34-0.21-0.05-0.63-0.08
-0.76-0.23-0.4-0.5-0.83-0.07-0.5-0.89-0.47-0.850.2-0.95-0.69-0.8-0.50.3-0.7-0.81-0.680.59-0.10.790.190.130.21
0.91-0.22-0.020.90.61-0.74-0.50.611.00.49-0.030.450.330.480.99-0.370.450.440.45-0.09-0.15-0.16-0.180.59-0.18
0.870.310.320.640.98-0.03-0.890.610.60.92-0.40.920.650.920.6-0.50.680.750.63-0.520.03-0.7-0.330.13-0.37
0.91-0.2-0.030.910.6-0.75-0.471.00.60.47-0.030.430.310.481.0-0.350.420.420.41-0.08-0.15-0.13-0.180.65-0.17
0.750.220.090.570.920.06-0.850.490.920.47-0.520.920.50.90.47-0.540.560.710.64-0.53-0.21-0.8-0.30.07-0.35
-0.18-0.4-0.11-0.05-0.54-0.30.2-0.03-0.4-0.03-0.52-0.28-0.26-0.590.030.8-0.26-0.32-0.140.530.020.330.66-0.190.69
0.740.310.310.490.860.11-0.950.450.920.430.92-0.280.620.870.45-0.290.620.780.65-0.570.0-0.84-0.16-0.1-0.21
0.520.480.770.080.660.19-0.690.330.650.310.5-0.260.620.540.3-0.420.960.860.29-0.450.63-0.31-0.26-0.19-0.28
0.750.380.280.560.920.06-0.80.480.920.480.9-0.590.870.540.48-0.560.540.70.57-0.66-0.01-0.78-0.340.18-0.39
0.91-0.21-0.030.920.58-0.76-0.50.990.61.00.470.030.450.30.48-0.290.410.420.43-0.08-0.16-0.16-0.130.63-0.12
-0.43-0.07-0.19-0.29-0.67-0.070.3-0.37-0.5-0.35-0.540.8-0.29-0.42-0.56-0.29-0.47-0.51-0.320.53-0.10.220.65-0.30.66
0.60.410.590.190.690.07-0.70.450.680.420.56-0.260.620.960.540.41-0.470.850.27-0.340.45-0.28-0.22-0.1-0.24
0.640.240.570.280.760.18-0.810.440.750.420.71-0.320.780.860.70.42-0.510.850.46-0.640.42-0.5-0.27-0.02-0.3
0.59-0.290.270.530.62-0.18-0.680.450.630.410.64-0.140.650.290.570.43-0.320.270.46-0.59-0.02-0.74-0.35-0.12-0.35
-0.32-0.2-0.58-0.15-0.57-0.370.59-0.09-0.52-0.08-0.530.53-0.57-0.45-0.66-0.080.53-0.34-0.64-0.59-0.370.620.50.060.5
-0.070.30.92-0.390.050.34-0.1-0.150.03-0.15-0.210.020.00.63-0.01-0.16-0.10.450.42-0.02-0.370.15-0.25-0.24-0.23
-0.45-0.17-0.17-0.32-0.65-0.210.79-0.16-0.7-0.13-0.80.33-0.84-0.31-0.78-0.160.22-0.28-0.5-0.740.620.150.10.30.14
-0.250.0-0.32-0.17-0.44-0.050.19-0.18-0.33-0.18-0.30.66-0.16-0.26-0.34-0.130.65-0.22-0.27-0.350.5-0.250.1-0.190.99
0.45-0.15-0.290.630.19-0.630.130.590.130.650.07-0.19-0.1-0.190.180.63-0.3-0.1-0.02-0.120.06-0.240.3-0.19-0.18
-0.27-0.04-0.32-0.17-0.48-0.080.21-0.18-0.37-0.17-0.350.69-0.21-0.28-0.39-0.120.66-0.24-0.3-0.350.5-0.230.140.99-0.18
Click cells to compare fundamentals

CEL SCI Account Relationship Matchups

CEL SCI fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets40.5M75.9M50.5M30.5M35.1M36.9M
Other Current Liab102.2K863.9K(417.5K)1.6M1.8M1.8M
Total Current Liabilities4.3M3.9M4.7M5.6M6.4M3.6M
Total Stockholder Equity19.7M56.5M32.2M13.2M15.2M8.4M
Property Plant And Equipment Net20.9M28.4M24.7M21.0M24.2M25.4M
Net Debt(1.6M)(20.1M)(7.4M)9.4M8.5M8.9M
Retained Earnings(381.8M)(418.2M)(454.9M)(487.1M)(438.4M)(416.5M)
Cash15.5M36.1M22.7M4.1M4.8M7.7M
Non Current Assets Total22.8M30.6M25.1M23.6M27.2M28.5M
Cash And Short Term Investments15.5M42.2M22.7M4.1M4.8M8.1M
Common Stock Shares Outstanding36.8M40.7M43.1M44.5M51.2M53.7M
Liabilities And Stockholders Equity40.5M75.9M50.5M30.5M35.1M36.9M
Other Current Assets1.3M998.5K762.1K524.6K472.2K448.5K
Other Stockholder Equity401.2M474.3M486.6M499.8M574.8M603.5M
Total Liab20.8M19.3M18.4M17.3M19.9M20.9M
Property Plant And Equipment Gross5.8M32.5M30.6M29.0M33.3M35.0M
Total Current Assets17.7M45.3M25.4M6.9M8.0M9.9M
Non Current Liabilities Total16.5M15.4M13.7M11.7M13.5M14.2M
Short Long Term Debt Total13.9M16.0M15.3M13.6M15.6M16.4M
Short Term Debt2.1M1.4M3.5M2.0M2.3M1.2M
Intangible Assets313.4K275.9K212.2K197.7K177.9K284.1K
Accounts Payable2.0M1.7M1.6M2.0M2.3M1.4M
Net Receivables118.7K62.8K54.9K(2.0M)(1.8M)(1.7M)
Common Stock Total Equity352.3K387.3K432.1K434.5K499.7K959.4K
Common Stock387.3K432.1K434.5K474.2K426.8K682.4K
Other Liab7.0M6.0M3.7M125K143.8K136.6K
Property Plant Equipment15.8M5.8M13.7M12.1M13.9M14.6M
Inventory820.1K2.0M2.0M2.2M2.6M2.7M
Net Tangible Assets5.1M19.4M56.3M32.0M36.7M38.6M
Retained Earnings Total Equity(353.7M)(381.8M)(418.2M)(454.9M)(409.4M)(429.9M)
Capital Surpluse358.5M401.2M474.3M486.6M559.6M351.9M
Non Current Liabilities Other13.5M13.0M125K13.7M143.8K136.6K
Long Term Debt Total13.5M11.8M13.3M11.7M13.5M12.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.61)
Return On Equity
(2.50)
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.